Matches in Nanopublications for { ?s ?p "Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. FDA approved on September 24, 2009."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.